NeoGenomics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -32.3% | +235.9% | -16.0% | +148.3% | -47.8% | -93.8% | -1,930.3% | – | – | – | -25.5% | |
| – | +26.6% | +225.0% | -2.7% | -3.8% | +39.3% | +18.0% | +49.4% | +30.1% | +4.5% | 0.0% | -6.5% | |
| – | +402.7% | +56.3% | +18.4% | +8.0% | +43.8% | +2.1% | +119.9% | +9.9% | -0.2% | +35.6% | +23.7% | |
| – | +69.2% | +310.9% | +23.4% | -73.7% | +58.4% | +18.6% | -634.5% | – | – | – | – | |
| – | – | – | – | – | -359.1% | – | – | – | – | – | – | |
| – | -41.3% | +240.2% | +81.7% | +4.5% | +40.0% | +45.3% | +120.4% | -51.8% | -6.9% | +42.8% | -34.2% | |
| – | +682.7% | -91.3% | +110.6% | +920.4% | -85.9% | +712.2% | +296.6% | – | +14,736.9% | -83.2% | -196.0% | |
| – | – | – | -100.0% | – | – | – | – | – | – | – | – | |
| – | -97.5% | -5,982.4% | – | -2,037.2% | – | +81.3% | -25.8% | -16.5% | – | – | – | |
| – | – | -55.9% | -126.3% | -69.5% | +160.4% | – | +241.9% | -100.2% | -100.0% | – | – | |
| – | +101.7% | -144.2% | -84.2% | – | +73.4% | +47.7% | +207.8% | -98.4% | -61.5% | +2.0% | -4,411.0% | |
| – | -135.6% | – | – | -1,116.9% | – | -52.4% | -14.7% | -181.0% | – | -69.1% | -945.7% | |
| – | -26.4% | +233.7% | -68.8% | +601.1% | -89.0% | -927.4% | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.